Not in the current Orange Book— This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
CARFILZOMIB | A209526 | MSN
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Onyx Therapeutics, Inc. v. MSN Pharmaceuticals, Inc. et al 10 patentsANDA 209526carfilzomib | D. Del. | 2017-12-20 | Terminated 2019-05-08 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.